Sevilito CMC Biotech ApS
CVR 45431509 · Private limited company (ApS) · Active · Low risk
Sevilito CMC Biotech ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry anden teknisk rådgivning. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 27k and a net result of DKK -13k. CEO: Tore Bengt Søderblom.
Bankruptcy risk for Sevilito CMC Biotech ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45431509
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- c/o Tore Søderblom, Pakhusvej 4, 1. th
2100 København Ø - Municipality
- København
- Industry
- Anden teknisk rådgivning (711290)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 100.0% |
| Current ratio | – |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Revenue | DKK 38k |
| Gross profit | DKK -13k |
| Net profit | DKK -13k |
| Equity | DKK 27k |
| Total assets | DKK 27k |
| Cash | DKK 27k |
Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 28 Feb 2025 – 31 Dec 2025 | 58 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Tore Bengt Søderblom | Current | |
| Owner (100%) | Tore Bengt Søderblom | Current | |
| Founder | Tore Bengt Søderblom | Current |
Address history (1 moves)
| c/o Tore Søderblom, Pakhusvej 4, 1. th, 2100 København Ø | |
| Pakhusvej 4, 1. th, 2100 København Ø |
Other companies at the same address
- CRAFTWORK DESIGN ApS Opløst
Similar companies in København
- BOBACH ApS København K
- SCANDINAVIAN JOINT SHIPPING SERVICE ApS København Ø
- Saka Energy Consulting Aps Vanløse
- Forberedt ApS København S
- LUMAIQ Lysteknik ApS København NV
- Navitas-Consult ApS København S
- Enectrify ApS Hellerup
- Paebbl Denmark ApS København Ø
- SHB Legacy ApS København S
- Equus Energy Systems ApS København NV
- PR Tryghed ApS København Ø
- Nunchi Climate Group ApS Brønshøj
Questions and answers about Sevilito CMC Biotech ApS
Has Sevilito CMC Biotech ApS gone bankrupt?
No, Sevilito CMC Biotech ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Sevilito CMC Biotech ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of Sevilito CMC Biotech ApS?
Tore Bengt Søderblom is the CEO of Sevilito CMC Biotech ApS.
When was Sevilito CMC Biotech ApS founded?
Sevilito CMC Biotech ApS was founded on 28 February 2025.
What is the equity of Sevilito CMC Biotech ApS?
Equity was DKK 27k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.